Cancer

Johnson & Johnson to pay $40 million to two women in ovarian cancer suit

On December 12, the jury directed Johnson & Johnson to pay $18 million to Monica Kent and $22 million to Deborah Schultz and her husband

Aster DM Healthcare to invest ₹120 cr in 5 cancer centres for poor patients

Aster DM Healthcare on Thursday announced an investment of Rs 120 crore to set up five advanced Oncology Radiation LINAC Centres across India to support underprivileged cancer patients, under its CSR initiative. The programme aims to provide free and subsidised high-quality radiation therapy to cancer patients from economically weaker sections who are unable to afford or continue life-saving treatment, the company said in a statement. The first centre will be established in Wayanad, Kerala, catering to the wider Malabar region, including neighbouring areas such as Gudalore and Gudalpet, it added. The remaining centres will be developed in strategic locations, including Bengaluru and other cities, over the next three years, based on community needs and clinical feasibility, the company said. "By establishing five state-of-the-art radiation LINAC therapy centres, we aim to bridge critical gaps in oncology services and ensure that patients receive timely, lifesaving treatment closer t

Zydus Lifesciences introduces biosimilar for cancer patients' bone health

Zydus Lifesciences on Wednesday said it has launched a biosimilar for the treatment of osteoporosis and the prevention of skeletal complications in cancer patients. The company has launched Zyrifa, a Denosumab biosimilar. Denosumab is a monoclonal antibody with several indications related to bone health, primarily in the treatment of osteoporosis and the prevention of skeletal complications in cancer patients. This will provide access and treat patients with bone metastases due to breast, prostate, lung, myeloma, kidney, thyroid, head & neck, and other solid tumours, the Ahmedabad-based drug firm said in a regulatory filing. Metastases, is when the cancer spreads to the bones and other organs in the body indicating an advanced stage of cancer. The company said it has priced 'Zyrifa' at MRP of Rs 12,495. Sharvil P Patel, Managing Director, Zydus Lifesciences Ltd said that with Denosumab 120 mg SC, the company aims to bring access, affordability of medication in cancer patients ...

Cancer crisis intensifies globally, hitting low-resource countries hardest

Once seen as a disease of the wealthy, cancer now affects all regions, with a growing share of cases and deaths occurring in low- and middle-income countries

Sonali Bendre says autophagy helped her cancer recovery. Doctors disagree

Sonali Bendre credited autophagy for aiding her recovery from metastatic cancer, but doctors warn the cell-recycling process triggered by fasting is not a treatment and cannot kill cancer cells

Morphle Labs raises $5 million to automate core of cancer diagnostics

Inflexor Ventures-led round backs robotic microtomy and high-throughput imaging systems as the startup accelerates global expansion and regulatory approvals

JFK's granddaughter reveals cancer diagnosis, criticises cousin RFK Jr

John F. Kennedy's granddaughter disclosed Saturday that she has terminal cancer, writing in an essay in The New Yorker that one of her doctors said she might live for about another year. Tatiana Schlossberg, the daughter of Kennedy's daughter, Caroline Kennedy, and Edwin Schlossberg, wrote that she was diagnosed in May 2024 at 34 when, after the birth of her second child, her doctor noticed her white blood cell count was high. It turned out to be acute myeloid leukemia with a rare mutation, mostly seen in older people, she wrote. Schlossberg, an environmental journalist, wrote she has undergone rounds of chemotherapy and two stem cell transplants, the first using cells from her sister and the next from an unrelated donor, and participated in clinical trials. During the latest trial, she wrote that her doctor told her he could keep me alive for a year, maybe. Schlossberg noted that her cousin, Robert F. Kennedy, Jr. was on the national stage, first running for president and later ..

What myths about breast cancer could be putting your life at risk?

From bras and breastfeeding to lump anxiety and radiation fears, doctors break down the myths that stop men and women alike from getting timely breast cancer screening

Breast cancer myths busted: Awareness isn't enough, action saves lives

Can young women or men get breast cancer? Are mammograms unsafe? In this episode of our fact-check series, doctors debunk the biggest breast health myths and explain why regular screening saves lives.

Breast cancer: Why do so many women still avoid mammograms in India?

Why do myths, modesty and misinformation still overshadow one of medicine's best defences against breast cancer? Experts say it is time to make mammograms as routine as blood pressure checks

Men get breast cancer too, but most find out far too late, say doctors

Breast cancer affects men too, yet most don't know the symptoms. Experts explain warning signs, risks, and why awareness matters

Why more young women are being diagnosed with breast cancer today

Breast cancer is rising among women under 40, with aggressive subtypes becoming more common. Experts urge early awareness, genetic testing, and regular breast self-exams

mRNA Covid shots could make cancer immunotherapy more effective, says study

Scientists have found that Covid-19 mRNA vaccines could enhance immune responses in cancer patients, potentially transforming how immunotherapy works

Study finds disparities in cancer research in India despite economic growth

India had a largely inconsistent growth in clinical research related to cancer since 2001, despite a strong economic growth, suggesting that development could be a contributing factor towards disparities among the low and middle-income countries in cancer research, according to a new study. Cancer cases and deaths are projected to surge in the coming decades with low and middle-income countries expected to bear a disproportionate burden. However, researchers, including those from the the Latin American Cooperative Oncology Group, said that clinical trials of cancer are disproportionally concentrated in high-income countries, even as previous evidence suggests an increase in trials among low and middle-income nations. The study, published in the journal 'CANCER', looked at disparities in the numbers and complexity of clinical trials over time and according to economic changes. Datasets from World Bank and ClinicalTrials.gov were analysed. Between 2001 and 2020, a total of 16,977 can

Ozempic-like medications may trigger false cancer signals on scans

A new study finds that GLP-1 weight-loss drugs such as Ozempic and Wegovy may alter PET-CT cancer scans, raising concerns about false positives and unnecessary treatment risks

'Positive power': Nafisa Ali embraces bald look amid stage 4 cancer battle

Bollywood veteran actress Nafisa Ali, who has been fighting stage 4 ovarian and peritoneal cancer since 2018, bravely and gracefully displayed her 'bald' look while undergoing chemotherapy

NSE to build ₹380-cr facility for cancer treatment at Tata Memorial Centre

Country's largest equity bourse NSE on Sunday announced that it will spend Rs 380 crore to build a facility to help in cancer treatment at Tata Memorial Hospital. The 11-storey NSE multi-speciality hospital block and bone marrow transplant (BMT) centre will come up at TMC-run ACTREC in the satellite city of Navi Mumbai. Groundbreaking for the facility being constructed by L&T was conducted on Sunday, an official statement said, adding that the BMT centre will be the largest of such facilities in the country. The facility is projected to serve approximately 1.3 lakh out patients department (OPD) visits every year, conduct over 600 BMT procedures in a year and also have 60 beds. The project being funded through NSE's corporate social responsibility efforts has a built up area of 2.4 lakh sq ft and is likely to commence operations by July 2027, it said. NSE Foundation has partnered with the TMH established Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) for .

Cancer attributable to prolonged stress suffered in Army job, says HC

The Punjab and Haryana High Court has dismissed the Centre's plea against grant of special family pension to an Army personnel who died due to cancer, observing that stress and strain for a prolonged period in military service can lead to the malady. The court also cited rules governing employees of the petitioner which stated that except for cancer due to smoking, the rest of the cancers have been treated to be attributable to military service. A division bench of Justices Harsimran Singh Sethi and Vikas Suri made these observations while rejecting the Centre's petition challenging a 2019 order of the Armed Forces Tribunal (Chandigarh). The tribunal had directed that Kumari Salochna Verma be granted special family pension from the date of her son's death. The petitioner's counsel submitted that Verma's son suffered from retroperitoneal sarcoma with widespread metastasis and died on June 24, 2009. The disease was found by the medical board to be "neither attributable to nor aggrav

Why more young people are being diagnosed with cancer than ever before

In the last decade, more than a dozen types of cancer have risen among people under 50. Scientists don't have all of the answers, but research is starting to offer clues

Trump signs executive order to accelerate pediatric cancer research

Trump stated that in 2019, he launched the Childhood Cancer Data Initiative and has now doubled the investment in the sector